RIT1 and lung adenocarcinoma: The comprehensive molecular profiling in lung adenocarcinoma by TCGA research network has shown that 75% of lung adenocarcinomas have genetic alterations that promote RTK/RAS/RAF pathway; these genetic alterations included newly identified NF1 and RIT1 mutations, both of which are potentially targetable (3).